This data is supported by a number of previous studies that have demonstrated that upregulation of GRP78 results in the chemoresistance phenotype of breast cancer, malignant gliomas and tumor associated endothelia cells (100,107,108). The gene discussed is HSPA5; the disease is breast carcinoma.